Novartis Benefits From Lack of Generic Challenge

April 24 (Bloomberg) -- Bloomberg's Jonathan Ferro reports that Novartis AG saw first-quarter profit rise 7 percent as a competitor's generic version of the company’s second-best-selling medicine failed to reach the market. He speaks on Bloomberg Television's "On The Move."

The Dash-Cam App That Aims to Prevent Car Crashes
40:35 - It's an app that plans to rate every car on the road, and predict and prevent accidents before they happen. Nexar, which launches today on Apple's App store is based in Tel Aviv. Bloomberg’s Middle East Editor, Elliott Gotkine, took it for a spin.
  • There's a Loss of Faith in Central Banks: JPM's Ulrich
  • Market Turmoil: What Will Stop the Selloff?
  • Cantor Fitzgerald's Cecchini: Rally in Store for Stocks